Israel Englander’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.9M | Buy |
3,079,542
+856,785
| +39% | +$8.27M | 0.02% | 965 |
|
|
2026
Q1 | $16.5M | Sell |
2,222,757
-2,981,652
| -57% | -$31.4M | 0.01% | 1706 |
|
|
2025
Q4 | $61.2M | Sell |
5,204,409
-770,217
| -13% | -$8.31M | 0.03% | 678 |
|
|
2025
Q3 | $46.1M | Buy |
5,974,626
+2,657,818
| +80% | +$18.6M | 0.02% | 933 |
|
|
2025
Q2 | $24.2M | Sell |
3,316,808
-3,401,493
| -51% | -$27.5M | 0.01% | 1394 |
|
|
2025
Q1 | $63.8M | Buy |
6,718,301
+5,292,512
| +371% | +$66.1M | 0.03% | 594 |
|
|
2024
Q4 | $23.5M | Buy |
1,425,789
+1,385,514
| +3,440% | +$21.5M | 0.01% | 1380 |
|
|
2024
Q3 | $594K | Buy |
+40,275
| New | +$630K | ﹤0.01% | 4695 |
|
|
2024
Q1 | – | Sell |
-180,714
| Closed | -$2.79M | – | 6491 |
|
|
2023
Q4 | $2.92M | Buy |
180,714
+99,477
| +122% | +$1.63M | ﹤0.01% | 3274 |
|
|
2023
Q3 | $999K | Sell |
81,237
-48,442
| -37% | -$720K | ﹤0.01% | 4185 |
|
|
2023
Q2 | $2.08M | Buy |
129,679
+41,980
| +48% | +$692K | ﹤0.01% | 3450 |
|
|
2023
Q1 | $1.53M | Sell |
87,699
-2,569,778
| -97% | -$36.6M | ﹤0.01% | 3694 |
|
|
2022
Q4 | $24.6M | Buy |
2,657,477
+1,982,840
| +294% | +$18.5M | 0.01% | 1266 |
|
|
2022
Q3 | $5.81M | Sell |
674,637
-1,489,626
| -69% | -$14.8M | ﹤0.01% | 2753 |
|
|
2022
Q2 | $17.6M | Buy |
2,164,263
+1,626,337
| +302% | +$15.5M | 0.01% | 1434 |
|
|
2022
Q1 | $6.54M | Buy |
537,926
+480,385
| +835% | +$10.1M | ﹤0.01% | 2639 |
|
|
2021
Q4 | $1.96M | Buy |
57,541
+34,371
| +148% | +$1.35M | ﹤0.01% | 3800 |
|
|
2021
Q3 | $1.12M | Sell |
23,170
-52,507
| -69% | -$2.43M | ﹤0.01% | 4549 |
|
|
2021
Q2 | $3.42M | Sell |
75,677
-187,059
| -71% | -$8.29M | ﹤0.01% | 3279 |
|
|
2021
Q1 | $12.7M | Buy |
262,736
+230,947
| +726% | +$12M | 0.01% | 1531 |
|
|
2020
Q4 | $1.71M | Sell |
31,789
-148,144
| -82% | -$6.69M | ﹤0.01% | 3359 |
|
|
2020
Q3 | $6.64K | Buy |
+179,933
| New | +$6.69M | 0.01% | 1582 |
|
|
2019
Q4 | – | Sell |
-221,668
| Closed | -$4.24M | – | 4497 |
|
|
2019
Q3 | $4.24M | Buy |
+221,668
| New | +$5.2M | 0.01% | 1935 |
|
|
2019
Q1 | – | Sell |
-770,201
| Closed | -$9.71M | – | 4206 |
|
|
2018
Q4 | $9.71M | Buy |
770,201
+758,552
| +6,512% | +$11.3M | 0.02% | 1152 |
|
|
2018
Q3 | $179K | Sell |
11,649
-24,274
| -68% | -$336K | ﹤0.01% | 3663 |
|
|
2018
Q2 | $471K | Buy |
+35,923
| New | +$395K | ﹤0.01% | 3188 |
|
|
2017
Q3 | – | Sell |
-49,978
| Closed | -$448K | – | 3739 |
|
|
2017
Q2 | $448K | Sell |
49,978
-146,904
| -75% | -$1.17M | ﹤0.01% | 2863 |
|
|
2017
Q1 | $1.55M | Buy |
196,882
+112,727
| +134% | +$918K | ﹤0.01% | 2151 |
|
|
2016
Q4 | $721K | Sell |
84,155
-105,835
| -56% | -$907K | ﹤0.01% | 2436 |
|
|
2016
Q3 | $1.56M | Sell |
189,990
-275,324
| -59% | -$2.31M | ﹤0.01% | 2063 |
|
|
2016
Q2 | $3.74M | Buy |
+465,314
| New | +$3.73M | 0.01% | 1436 |
|
|
2016
Q1 | – | Sell |
-192,915
| Closed | -$1.52M | – | 3527 |
|
|
2015
Q4 | $1.52M | Buy |
192,915
+133,615
| +225% | +$979K | ﹤0.01% | 2097 |
|
|
2015
Q3 | $340K | Sell |
59,300
-59,914
| -50% | -$371K | ﹤0.01% | 2851 |
|
|
2015
Q2 | $645K | Sell |
119,214
-313,125
| -72% | -$1.61M | ﹤0.01% | 2502 |
|
|
2015
Q1 | $2.02M | Buy |
432,339
+12,938
| +3% | +$56.3K | ﹤0.01% | 1937 |
|
|
2014
Q4 | $1.75M | Buy |
419,401
+257,651
| +159% | +$1.18M | ﹤0.01% | 2082 |
|
|
2014
Q3 | $843K | Buy |
161,750
+75,295
| +87% | +$387K | ﹤0.01% | 2429 |
|
|
2014
Q2 | $287K | Sell |
86,455
-32,985
| -28% | -$110K | ﹤0.01% | 2894 |
|
|
2014
Q1 | $414K | Buy |
119,440
+85,463
| +252% | +$320K | ﹤0.01% | 2737 |
|
|
2013
Q4 | $123K | Buy |
+33,977
| New | +$118K | ﹤0.01% | 3321 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Israel Englander's NEO Position: Q2 2026 in Review
Israel Englander increased its NeoGenomics (NEO) stake by 39% in Q2 2026, buying an estimated $8.27M and bringing the position to 3,079,542 shares worth $44.9M. The position accounts for 0.02% of the portfolio, ranked #965.
Israel Englander first reported a position in NEO in Q4 2013 and has held it in 40 quarters since. The position peaked at $63.8M in Q1 2025. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Israel Englander held 3,079,542 shares of NeoGenomics worth $44.9M as of Q2 2026.
- Israel Englander bought 856,785 NeoGenomics shares in Q2 2026, an estimated $8.27M.
- NeoGenomics made up 0.02% of Israel Englander's portfolio in Q2 2026, its #965 holding.
- Israel Englander first reported a position in NeoGenomics in Q4 2013 and has held it in 40 quarters since.
- Israel Englander's NeoGenomics position peaked at $63.8M in Q1 2025.
- 265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.